Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).

BACKGROUND For prevention and treatment of sarcopenia, defined as a decline in lean mass, reliable diagnostic criteria and cutpoints reflecting a clinically relevant threshold are indispensable. As of yet, various parameters have been proposed but no gold standard exists. The aim of this study was to compare cutpoints of appendicular lean mass related to body mass index (ALMBMI) or height (ALM/height(2)) regarding their association with self-reported physical limitations and frailty status in a sample of community-dwelling older adults. METHODS A total of 1,343 participants from the Berlin Aging Study II were included. ALM index was assessed with dual-energy X-ray absorptiometry. Limitations in physical performance were assessed via questionnaire and frailty status was defined according to the Fried criteria. RESULTS In a risk factor-adjusted analysis, participants with an ALMBMI below the cutpoints had 1.4-2.8 times higher odds of difficulties in several domains of physical activity (p = .031 to p < .0001) compared with participants with normal ALMBMI. In participants with low ALM/height(2), no associations with physical limitations were found. Moreover, the odds of being prefrail/frail were statistically significant for the low ALMBMI group only (odds ratio = 2.403, 95% confidence interval: 1.671-3.454, p < .0001) and not for the low ALM/height(2) group. CONCLUSIONS This study showed striking differences between the two operational criteria ALM/height(2) and ALMBMI concerning their association with physical limitations and prefrailty/frailty. The low ALMBMI cutpoints seem suitable to detect patients at risk for negative outcomes such as frailty who might benefit from interventions targeted at improving lean mass.

[1]  Maren S Fragala,et al.  An Evidence-Based Comparison of Operational Criteria for the Presence of Sarcopenia , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  Maren S Fragala,et al.  Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  Maren S Fragala,et al.  Cutpoints for Low Appendicular Lean Mass That Identify Older Adults With Clinically Significant Weakness , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  Maren S Fragala,et al.  Grip Strength Cutpoints for the Identification of Clinically Relevant Weakness , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  S. Bartels,et al.  Variation in the Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults Associated with Different Research Definitions: Dual‐Energy X‐Ray Absorptiometry Data from the National Health and Nutrition Examination Survey 1999–2004 , 2013, Journal of the American Geriatrics Society.

[7]  Douglas P Kiel,et al.  Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  J. Morley.  Sarcopenia in the elderly. , 2012, Family practice.

[9]  M. Narici,et al.  Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort , 2012, AGE.

[10]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[11]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[12]  S. Bandinelli,et al.  Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. , 2006, The American journal of clinical nutrition.

[13]  L. Ferrucci,et al.  Phenotype of frailty: characterization in the women's health and aging studies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  S. Rubin,et al.  Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function , 2003, Journal of the American Geriatrics Society.

[15]  B. Sternfeld,et al.  Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. , 2002, American journal of epidemiology.

[16]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[17]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  M. Visser,et al.  Skeletal Muscle Mass and Muscle Strength in Relation to Lower‐Extremity Performance in Older Men and Women , 2000, Journal of the American Geriatrics Society.

[19]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[20]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[21]  Shu-Chen Li,et al.  COHORT PROFILE Cohort Profile : The Berlin Aging Study II ( BASE-II ) y , 2013 .

[22]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[23]  John G. Orme,et al.  Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale. , 1986, Journal of clinical psychology.